FDA Inspection
Bracco Diagnostics, Inc.Bracco Diagnostics, Inc. – FDA Inspection, Nov 27, 2024
Record Details
This FDA Inspection record concerns Bracco Diagnostics, Inc., with an inspection on November 27, 2024, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · d8ae4b2a-425e-4deb-b9cc-7fb2caafb3cd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1235540
- FDA center
- Human Drugs
- Project area
- Postmarketing Surveillance and Epidemiology: Human Drugs
FDA Citations
2- 21 CFR 314.80(c)(1)(i)Late submission of 15-day report
- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bracco Diagnostics, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 5, 2017 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 30, 2014 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 13, 2013 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 27, 2012 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 8, 2012 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Bracco Diagnostics, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.